Chemogenomic analysis identifies Macbecin II as a compound specific for SMAD4-negative colon cancer cells.
Kaiser
Christine
C
Pharmaceutical Genomics Division, The Translational Genomics Research Institute, Scottsdale, AZ 85259, USA.
Meurice
Nathalie
N
Gonzales
Irma M
IM
Arora
Shilpi
S
Beaudry
Christian
C
Bisanz
Kristen M
KM
Robeson
Alexander C
AC
Petit
Joachim
J
Azorsa
David O
DO